ALPRE.PA · Predilife S.A
-
-
| Sector | Healthcare |
|---|---|
| Exchange | PA |
| CurrencyCode | EUR |
| ISIN | FR0010169920 |
| Industry | Diagnostics & Research |
| Beta | 0.38 |
|---|---|
| Market Cap | 14M |
| PE Ratio | None |
| Target Price | 20.92 |
| Dividend Yield | None |
ABOUT
Predilife S.A
Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides Breast Cancer Predictive Assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. Its products include MammoRisk, a a breast cancer prediction test based on the patient's individual risk; and DenSeeMammo, a breast density measurement software. Predilife S.A. was incorporated in 2004 and is headquartered in Villejuif, France.
Learn More